Acurx Pharmaceuticals, Inc. (ACXP)
2.28
-0.10
(-4.20%)
USD |
NASDAQ |
Apr 20, 09:51
Acurx Pharmaceuticals SG&A Expense (Quarterly) : 1.335M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Apyx Medical Corp. | 6.377M |
| Quince Therapeutics, Inc. | 3.635M |
| Lantern Pharma, Inc. | 1.458M |
| Sensei Biotherapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 155.62M |